| Bispecific antibodies in cancer immunotherapy: a novel response to an old question C Ordóñez-Reyes, JE Garcia-Robledo, DF Chamorro, A Mosquera, ... Pharmaceutics 14 (6), 1243, 2022 | 23 | 2022 |
| STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ... Lung Cancer 170, 114-121, 2022 | 22 | 2022 |
| Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies JM González, WJ Shelton, M Díaz-Vallejo, VE Rodriguez-Castellanos, ... MedRxiv, 2020.04. 10.20061150, 2020 | 16 | 2020 |
| Lung cancer in Colombia AF Cardona, SA Mejía, L Viola, DF Chamorro, L Rojas, A Ruíz-Patiño, ... Journal of Thoracic Oncology 17 (8), 953-960, 2022 | 8 | 2022 |
| Mechanisms of resistance to first-line osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (FRESTON-CLICaP) AF Cardona, A Ruiz-Patiño, G Recondo, C Martín, L Raez, S Samtani, ... Clinical Lung Cancer 23 (6), 522-531, 2022 | 7 | 2022 |
| Durvalumab after chemoradiation for unresectable stage III non-small cell lung cancer: inferior outcomes and lack of health equity in hispanic patients treated with PACIFIC … LE Raez, O Arrieta, DF Chamorro, PD Soberanis-Piña, L Corrales, ... Frontiers in oncology 12, 904800, 2022 | 7 | 2022 |
| Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an … DF Chamorro, AF Cardona, J Rodríguez, A Ruiz-Patiño, O Arrieta, ... Targeted Oncology 18 (3), 425-440, 2023 | 6 | 2023 |
| Integration of artificial intelligence and precision oncology in Latin America L Sussman, JE Garcia-Robledo, C Ordóñez-Reyes, Y Forero, ... Frontiers in Medical Technology 4, 1007822, 2022 | 6 | 2022 |
| Analysis of commercial assays for the detection of SARS-COV-2 antibodies or antigens JM González, WJ Shelton, M Díaz-Vallejo, VE Rodriguez-Castellanos, ... Open Journal of Immunology 10 (2), 21-35, 2020 | 5 | 2020 |
| DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients AF Cardona, DF Chamorro Ortiz, A Ruíz-Patiño, D Gomez, Á Muñoz, ... Neuro-Oncology Practice 10 (4), 381-390, 2023 | 4 | 2023 |
| Perspectiva oncológica de la medicina de precisión y su implementación en pacientes pediátricos y adultos con genes de fusión NTRK: una visión para Colombia C Vargas, C Sotelo, DF Chamorro, LE Pino, P Archila, LF Sua, ... Medicina 44 (2), 190-212, 2022 | 3 | 2022 |
| EP16. 03-003 Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC) S Mejia, J Rodríguez, A Ruiz-Patiño, P Archila, DF Chamorro, O Arrieta, ... Journal of Thoracic Oncology 17 (9), S586, 2022 | 1 | 2022 |
| Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies (preprint) JM Gonzalez, JW Shelton, M Diaz-Vallejo, VE Rodriguez-Castellanos, ... | 1 | 2020 |
| Abstract PO5-04-06: Enhancing Antitumor Activity of Her2 CAR T cells through TR2BB Co-Expression and Cytokine Signal 3 Incorporation D Chamorro, L Somes, E Madaras, S Nalawade, P Shafer, A Mosquera, ... Cancer Research 84 (9_Supplement), PO5-04-06-PO5-04-06, 2024 | | 2024 |
| Abstract PO4-06-08: ZP4 AS A NOVEL TARGET FOR CAR T CELL THERAPY IN TRIPLE NEGATIVE BREAST CANCER L Somes, J Lei, P Shafer, X Yi, D Chamorro, E Madaras, M Lewis, ... Cancer Research 84 (9_Supplement), PO4-06-08-PO4-06-08, 2024 | | 2024 |
| Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors C Sotelo-Rodríguez, D Vallejo-Ardila, A Ruiz-Patiño, DF Chamorro, ... JCO Global Oncology 10, e2300011, 2024 | | 2024 |
| Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential DF Chamorro, LK Somes, V Hoyos Cancers 16 (1), 124, 2023 | | 2023 |
| EP12. 01-65 Prognostic Value of Sequential Liquid Biopsy (LB) after Osimertinib Among Hispanic Patients with Advanced EGFR-Mutant NSCLC A Cardona, J Zuluaga, L Rojas, O Arrieta, A Ruiz-Patiño, J Rodríguez, ... Journal of Thoracic Oncology 18 (11), S667-S668, 2023 | | 2023 |
| EP12. 01-50 Real-World Characteristics and Outcomes of ERBB2-Mutant Non-small Cell Lung Cancer in Latin America Patients E Saldanha, VCC De Lima, M Corassa, O Arrieta, A Fares, LG Santana, ... Journal of Thoracic Oncology 18 (11), S661, 2023 | | 2023 |
| EP12. 03-04 Prognostic Value of TP53 Commutations Among Hispanic Patients with Advanced EGFR-positive NSCLC Treated with First Line Osimertinib L Rojas, J Zuluaga, A Ruiz-Patiño, J Rodríguez, O Arrieta, D Chamorro, ... Journal of Thoracic Oncology 18 (11), S681, 2023 | | 2023 |
Andres Felipe CardonaLuis Carlos Sarmiento Angulo Cancer Treatment and Research CenterVerified email at fctic.org
